Skip to content

Comment on Gilead’s update on response to COVID-19 using Remdesivirparent

Comments

If they get too greedy they risk China and others just copying it. The situation would allow for that. If they price it fairly, they can make a lot of money by selling hundreds of million doses within a few months. So there's a strong incentive to price it very reasonably.

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.